BW

Garmin® Ltd. schedules its fourth quarter 2021 earnings call

SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Garmin Ltd. (NYSE: GRMN) invites shareholders and investors to listen to its fourth quarter 2021 earnings conference call that will be broadcast over the Internet on Wednesday, February 16, 2022 at 10:30 a.m. EST, with executives of Garmin. The call will be held in conjunction with the company's…
Leer más...

BiologyWorks k(now)™ COVID-19 Clinical Trial Matches 99.1% Accuracy to RT-PCR Tests

BiologyWorks k(now)™ Handheld Molecular Testing Device Among the Most Accurate for COVID-19 LOS ANGELES--(BUSINESS WIRE)--$COVID #cemark--BiologyWorks™, Inc., a digital healthcare platform company, today announced that a substantive clinical trial of its handheld, reusable molecular test for COVID-19 matched 99.1% accuracy to laboratory RT-PCR tests. The independent clinical trial, conducted by…
Leer más...

Sonic Automotive Continues Expansion of its Franchised Dealership Network with the Acquisition of Sun Chevrolet

This Marks the Company’s 6th Chevrolet Franchise and 111th Franchised Dealership Location CHARLOTTE, N.C.--(BUSINESS WIRE)--Sonic Automotive Inc. (“Sonic” or the “Company”) (NYSE:SAH), a Fortune 500 Company and one of the nation’s largest automotive retailers, today announced the acquisition of Sun Chevrolet in Chittenango, New York. The dealership was founded by…
Leer más...

GRO Biosciences Appoints Rakhshita Dhar to its Board of Directors

BOSTON--(BUSINESS WIRE)--GRO Biosciences Inc. (“GRObio”), an emerging biotechnology company leveraging groundbreaking science to expand the amino acid alphabet and deliver on the promise of protein therapeutics, today announced the appointment of Rakhshita Dhar to its Board of Directors. Ms. Dhar is an expert in life sciences platform development, business development,…
Leer más...

Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin

-- Shipment of vasopressin, a generic alternative to Vasostrict®, commences today, with 180 days of marketing exclusivity -- -- Product launch expected to drive significant revenue growth in 2022 -- WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced the commercial availability of its recently…
Leer más...

Schrödinger Announces Acquisition of XTAL BioStructures, Inc.

Acquisition Expands Schrödinger’s Leadership in Structure-Based Drug Discovery NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced the acquisition of XTAL BioStructures, Inc., a private company based in the Greater Boston area that provides structural biology services, including…
Leer más...

Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine

Merck Allocates 3 Million Courses of Molnupiravir to be Provided in First Half of 2022 for Use in Low- and Middle-Income Countries KENILWORTH, N.J. & MIAMI--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced the signing of a long-term supply…
Leer más...